![]() |
市場調査レポート
商品コード
1363912
手術用縫合糸の世界市場:2023-2030年Global Surgical Sutures Market 2023-2030 |
||||||
カスタマイズ可能
|
手術用縫合糸の世界市場:2023-2030年 |
出版日: 2023年09月15日
発行: Orion Market Research
ページ情報: 英文 250 Pages
納期: 2~3営業日
|
世界の手術用縫合糸市場は予測期間(2023-2030年)にCAGR 5.8%で成長すると予測されています。医師は傷や裂傷を治療するために縫合糸を使用します。市場の成長は、縫合糸アンカーシステムやシトリジェンTMなどの技術的進歩に対する需要の高まりに起因しています。縫合糸アンカーシステムは、整形外科や軟部組織の処置の際に使用され、特に軟部組織と骨の間の確実で信頼性の高い結合が必要な場合に使用されます。従来の技術で軟部組織を骨に取り付けると、縫合糸が引き抜かれたり、失敗したりするなどの合併症が起こる可能性があります。そのため、各企業は縫合糸アンカーシステムの需要に対応する新製品を発表しています。例えば、2022年12月、Strykerは足関節手術用の縫合糸アンカーシステムCitrefix(TM)を発売しました。この新技術は、天然骨の組成と構造を模倣して作られ、高い評価を得ている生体吸収性物質であるシトレゲン(CitregenTM)を利用したものです。Citrefixは、使い捨て縫合糸用の生体吸収性縫合糸アンカーシステムです。
製品タイプの中では、吸収性サブセグメントが世界の手術用縫合糸市場で大きなシェアを占めると予想されています。このセグメントの成長は、縫合糸除去の必要性低減に対する需要の高まりに起因しています。吸収性縫合糸は、溶解性縫合糸としても知られています。吸収性縫合糸にはさまざまな利点がありますが、そのひとつは創傷が治癒した後に抜糸する必要がないため、時間を節約でき、患者の苦痛を最小限に抑えられることです。この性質により、特に深部組織の閉鎖や内部処置に適しています。吸収性縫合糸は、動物の腸を覆っている繊維や合成ポリマーなど、体内で容易に溶ける物質から作られています。吸収性縫合糸は、絹縫合糸やナイロン縫合糸のように専門的な剥離に依存しません。そのため、外科的切開や内部の傷の治癒に効果的です。
世界の手術用縫合糸市場は、北米(米国、カナダ)、欧州(英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域)、アジア太平洋地域(インド、中国、日本、韓国、その他アジア地域)、世界のその他の地域(中東とアフリカ、ラテンアメリカ)を含む地域別にさらに細分化されています。なかでも北米は、抗菌コーティングを施した生体適合性の高い手術用縫合糸など、革新的な手術手技や機器に対する需要の増加により、世界市場で突出したシェアを占めると予想されます。
すべての地域の中で、アジア太平洋地域は予測期間中にかなりのCAGRで成長すると予測されています。同地域の成長を後押ししている手術用縫合糸に対する需要の増加は、高齢者層における疾患の発生率の増加によるものと予測されています。冠動脈バイパス手術、大動脈弁や僧帽弁の交換や修復、動脈瘤の修復は一般的な心臓血管手術です。手術の重要な要素は縫合です。ステンレス鋼、ポリプロピレン、ポリエステル縫合糸は心臓縫合糸に使用される素材のひとつです。2020年1月にインド家族保健福祉省が発表した第1回インド縦断的高齢化調査(LASI)によると、インドでは高齢者の3人に1人が慢性疾患を抱えています。インドではほぼ70%の高齢者が慢性疾患を抱えています。調査によると、高齢者(60歳以上)の約23%が多疾病に罹患しており、高齢女性ほどその傾向が強いです。調査結果には、シッキムを除く全州と連邦直轄領の高齢者72,000人以上に相当する42,000以上の家庭からの情報が含まれています。
第1回インド縦断的高齢化調査(LASI)によると、45歳以上の人々が自己申告した重大な慢性健康障害や多疾病の数は、加齢とともに増加しました。心血管疾患(CVD)と高血圧は、75歳以上で顕著な慢性疾患です。高齢になるにつれて、罹患のない人の割合は減少の一途をたどっています。45歳以下では73%が罹患していないと推定されますが、75歳以上ではこの割合は44%に低下します。とはいえ、60歳以上になると、その減少幅は緩やかになります。
Title: Global Surgical Sutures Market Size, Share & Trends Analysis Report by Product Type (Absorbable Sutures, and Non-absorbable Sutures), by Application (Ophthalmic Surgery, Cardiovascular Surgery, Orthopedic Surgery, Neurology Surgery, and Others), and by End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Clinics and Physician Offices)Forecast Period (2023-2030).
The global surgical sutures market is anticipated to grow at a CAGR of 5.8% during the forecast period (2023-2030). Doctors use sutures to treat wounds and lacerations. The market's growth is attributed to growing demand for technological advancements such as suture anchor system, and citregenTM. Suture anchor systems are employed during orthopedic and soft tissue procedures, especially when a secure and reliable bond amongst the soft tissue and the bone is required. Complications such as suture pull-through or failure can occur when attaching soft tissues to bone using the conventional technique. Accordingly market players are coming up with new products to cater the demand for suture anchor system. For instance, in December 2022, Stryker launched a Citrefix™, a suture anchor system for foot and ankle surgical procedures. The new technology involves the utilization of CitregenTM, a highly acclaimed bioresorbable substance created to imitate the composition and structure of natural bone. Citrefix is a resorbable, bio-inspired suture anchor system for disposable sutures.
The global surgical sutures market is segmented on the product type, application, and end user. Based on the product type, the market is sub-segmented into absorbable sutures (natural sutures, synthetic sutures), and non-absorbable sutures (nylon, prolene, and others). Based on the application, the market is sub-segmented into ophthalmic surgery, cardiovascular surgery, orthopedic surgery, neurology surgery, and others. Further, on the basis of end-user, the market is sub-segmented into hospitals and clinics, ambulatory surgical centers, and clinics and physician offices. Among the application, the orthopedic surgery sub-segment is anticipated to hold a considerable share of the market owing to the numbers of orthopedic conditions influencing the senior citizen population and growing numbers of individuals seeking orthopedic surgery globally. For instance, according to National Institute of Health, globally, the incidence of arthritis was 203 per 10,000 individuals.
Among the product type, the absorbable sub-segment is expected to hold a significant share of the global surgical sutures market. The segmental growth is attributed to growing demand for reduced need for suture removal. Absorbable sutures, additionally known as dissolvable sutures. Absorbable sutures offer a variety of benefits such as, one of that is the fact that they don't need to be removed once the wound has healed, saving time and minimizing patient suffering. This quality makes them especially well-suited for deep tissue closures and interior procedures. They originate from substances that easily dissolve in the body, such as fibers that line the intestines of animals or synthetic polymers. Absorbable sutures are not dependent on professional removals such as silk or nylon sutures. They are therefore effective for healing surgical incisions and interior wounds.
The global surgical sutures market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, North America is anticipated to hold a prominent share of the market across the globe, owing to the increase in demand for innovative surgical techniques and equipment, such as biocompatible surgical sutures with antimicrobial coatings.
Among all regions, the Asia-Pacific regions is anticipated to grow at a considerable CAGR over the forecast period. The increasing demand for surgical sutures, that is subsequently fueling the region's growth, is projected to result from the disease's increased incidence among the older population. Coronary bypass surgery, aortic or mitral valve replacement or repair, and aneurysm repair are common cardiovascular procedures. A significant component of surgery is suturing. Stainless steel, polypropylene, and polyester sutures are among the materials utilized for cardiac sutures. According to the First Longitudinal Ageing Study in India (LASI), that was published by the Union Ministry of Family and Health Welfare in January 2020, both out of every three elderly individuals in India have a chronic illness. Almost 70% senior citizens in India have a chronic illness. According to the research, multi-morbidity conditions affect about 23% of senior citizens (60 years and older); older women are more likely to have such disorders. The survey's findings included information from more than 42,000 homes, representing more than 72,000 senior citizens in all states and union territories with the exception of Sikkim.
According to the First Longitudinal Ageing Study in India (LASI), the number of significant chronic health disorders and multi-morbidities that people over the age of 45 self-reported having increased with age. Cardiovascular diseases (CVD) and hypertension predominate among the chronic health disorders that are prominent among individuals 75 years of age and older. As individuals aged, the proportion of those without morbidity continually fell. It is estimated that 73% of people under the age of 45 are free of morbid conditions, and this percentage drops to 44% among individuals 75 and older. From the age of 60 onward, the decline is, nevertheless, slower.
The major companies serving the surgical sutures market include B.Braun SE, Coloplast Corp., DemeTECH Corp., Dolphin Sutures, Kono Seisakusho Co., Ltd., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in in April 2021, Dolphin Sutures, launched a non-absorbable polytetrafluoroethylene (PTFE) suture. PTFE is very strong, knots well, and is biologically inert.